DNC4
Latest Information Update: 30 May 2001
Price :
$50 *
At a glance
- Originator M. D. Anderson Cancer Center; Wellstat Therapeutics Corporation
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 30 Oct 1997 No-Development-Reported for Cancer in USA (Unknown route)
- 10 Nov 1995 Preclinical development for Cancer in USA (Unknown route)